Form EFFECT Barinthus Biotherapeutic

September 15, 2026 6:20 AM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: September 14, 2026
Accession Number: 0001104659-26-106326
Submission Type: POS AM
CIK: 0001828185
Company Name: Barinthus Biotherapeutics plc.
File Number: 333-265763


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings